Physician profile
Eric J Foreman
NPI 1083708028
$6,287.00
in general payments reported to CMS, 2019-2025
33 companies · $634 in 2025
The $634 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $247 · 2020: $125 · 2021: $2,909 · 2022: $279 · 2023: $1,629 · 2024: $464 · 2025: $634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,529 · Travel and Lodging: $1,198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,528.52 |
| Travel and Lodging | $1,198.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $2,007.25 | 2021-2023 | |
| Arthrex, INC. | $1,368.84 | 2021 | |
| Treace Medical Concepts, INC. | $502.01 | 2024-2025 | |
| Depuy Synthes Sales INC. | $405.26 | 2021-2025 | Motoband, Na, Speedtrap |
| Pinnacle, INC | $277.22 | 2021 | |
| Stryker Corporation | $203.13 | 2019-2025 | Allofiber, Citrefix, Tensix |
| Abbott Laboratories | $184.78 | 2019-2022 | |
| Avita Medical Americas, LLC | $145.61 | 2024 | |
| Cardiovascular Systems INC. | $141.46 | 2019-2022 | |
| Fusion Orthopedics USA, LLC | $116.42 | 2025 | |
| Paratek Pharmaceuticals, INC. | $111.52 | 2019-2023 | Nuzyra |
| Davol INC. | $96.03 | 2023 | |
| Kci USA, INC. | $74.91 | 2023 | V.A.C.Instill, Activ.A.C., Promogran Prisma |
| Bard Peripheral Vascular, INC. | $66.88 | 2025 | Rotarexs 6 F X 135 Cm |
| Abbvie INC. | $61.45 | 2021-2024 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $60.44 | 2021 | |
| Bioventus LLC | $55.71 | 2020-2025 | Xcell |
| Horizon Therapeutics Plc | $48.81 | 2021-2022 | |
| Axogen | $39.94 | 2019 | |
| Smith+Nephew, INC. | $38.95 | 2022 | |
| Anika Therapeutics, INC. | $31.07 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $30.55 | 2019-2021 | |
| Nevro Corp. | $27.83 | 2022 | |
| Wright Medical Technology, INC. | $27.72 | 2020 | |
| Melinta Therapeutics, LLC | $21.76 | 2021 | |
| Arthrosurface Incorporated | $19.77 | 2020 | |
| Boston Scientific Corporation | $19.59 | 2025 | General - Pain Management |
| Pacira Pharmaceuticals Incorporated | $19.51 | 2025 | Iovera |
| Djo, LLC | $18.88 | 2025 | Cmf |
| Paragon 28, INC. | $18.43 | 2025 | Monkey Rings |
| Heron Therapeutics, INC. | $17.04 | 2022 | |
| Grt US Holding, INC. | $14.72 | 2021 | |
| Polarityte, INC. | $13.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Foreman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.